Pharmabiz5m
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab: Hong Kong Friday, November 29, 2024, 10:00 Hrs [IST] Akeso, Inc., a leading biopharmace ...
Pharmabiz2h
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale: Shardul Nautiyal, Mumbai Friday, November 29, 2024, 08:00 Hrs [IST] The pharmaceutic ...
Pharmabiz2h
Parliamentary panel to delve into price rise of medicines, need for regulatory reforms among others
Parliamentary panel to delve into price rise of medicines, need for regulatory reforms among others: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departm ...
Pharmabiz2h
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departmen ...
Pharmabiz2h
UPF assures of 18 guarantees in its manifesto for election to WB SPC
UPF assures of 18 guarantees in its manifesto for election to WB SPC: Peethaambaran Kunnathoor, Chennai Friday, November 29, 2024, 08:00 Hrs [IST] Ahead of the upcoming state phar ...
Pharmabiz2h
Evidence-based clinical studies a cornerstone for advances in surgical technologies: Rohit Mahajan
Evidence-based clinical studies a cornerstone for advances in surgical technologies: Rohit Mahajan: Nandita Vijayasimha, Bengaluru Friday, November 29, 2024, 08:00 Hrs [IST] Evide ...
Pharmabiz13h
Exelixis updates from sNDA for cabozantinib to treat patients with previously treated advanced neuroendocrine tumours
Exelixis, a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care, announced that the US FDA has notified the company that the ...
Pharmabiz16h
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA: Calgary, Alberta Thursday, November 28, 2024, 18:00 Hrs [IST] Calg ...
Pharmabiz17h
NIHR Challenge Maternity Disparities Consortium members announced
Nine UK universities have been selected to make up the new NIHR Challenge Maternity Disparities Consortium, with the aim of tackling inequalities in maternity outcomes. The research carried out by the ...
Pharmabiz17h
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world: Our Bureau, Mumbai Thursday, November ...
Pharmabiz17h
Boehringer Ingelheim launches next generation poultry vaccine in India
Boehringer Ingelheim announced the launch of the latest advancement in Marek’s disease vaccines in India. This next generation vaccine offers enhanced protection through an innovative controlled ...
Pharmabiz18h
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ: Saint Herblain, France Thursday, November 28, 2024, 16:00 Hrs [IST] Valneva SE, a specialty ...